Bupivacaine liposomal 133mg/10ml prolonged-release dispersion for injection vials
in short Bupivacaine liposomal 133mg/10ml prolonged-rel inj vials
- SNOMED code
40163211000001101- Active compound
- Bupivacaine liposomal
- Preferred name basis
- rINN - Recommended International Non-proprietary
- Prescribable
- ✅ Yes
- Non-availability
- Actual Products not Available
- Non-availability date
- Dose form
- Discrete
- Dose size and units
- 10 ml, vial
- Ingredients
- Bupivacaine liposomal
— 13.3 mg
/ 1 ml
based on ingredient substance
- Form & Route
- dispersioninjectionprolonged-release.perineural, dispersioninjectionprolonged-release.infiltration
Prolonged-release dispersion for injection, PerineuralInfiltration - Controlled drug
- No Controlled Drug Status
Products
Exparel liposomal 133mg/10ml prolonged-release dispersion for injection vials (Pacira Ltd)
in short Exparel liposomal 133mg/10ml prolonged-rel inj vials
Exparel liposomal 133mg/10ml prolonged-release dispersion for injection vials
- SNOMED code
40114711000001106- Supplier
- Pacira Ltd
- Licensed as
- Medicines - MHRA/EMA
- Availability restrictions
- Not available
- Licensed routes
- Perineural, Infiltration
| Pack name & code | Status | GTIN, EAN barcodes | Price | Prescribing | Reimbursement | Pack |
|---|---|---|---|---|---|---|
Exparel liposomal 133mg/10ml prolonged-release dispersion for injection vials (Pacira Ltd) 10 vial40114811000001103 ref. pack |
Discontinued
Legal category: POM | 00365250133121 | NHS Indicative Price £1,349 | • Hospital |
| — |
Reference packs
Bupivacaine liposomal 133mg/10ml prolonged-release dispersion for injection vials 10 vial
- SNOMED code
40114611000001102- Quantity and unit
- 10 vial
- Packs